A Specifically Tailored Multistrain Probiotic and Micronutrient Mixture Affects Nonalcoholic Fatty Liver Disease-Related Markers in Patients with Obesity after Mini Gastric Bypass Surgery.
Silke CrommenKarl Peter RheinwaltAndreas PlamperMarie-Christine SimonDaniela RöslerRolf FimmersSarah EgertChristine MetznerPublished in: The Journal of nutrition (2022)
Supplementation with a specifically tailored probiotic and micronutrient mixture improved NAFLD-related markers more than a basic micronutrient mixture in obese patients following MGB surgery. The trial was registered under clinicaltrials.gov as NCT03585413.
Keyphrases
- gastric bypass
- obese patients
- bariatric surgery
- weight loss
- roux en y gastric bypass
- minimally invasive
- coronary artery bypass
- metabolic syndrome
- surgical site infection
- type diabetes
- smoking cessation
- clinical trial
- insulin resistance
- bacillus subtilis
- study protocol
- randomized controlled trial
- body mass index
- coronary artery disease
- phase iii
- drug induced
- liver fibrosis